Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
lamiVUDine-zidovudine
lamiVUDine-zidovudine
Brand names: Combivir
| Form | Strength |
|---|---|
| TABLET, ORAL | 150 mg-300 mg |
Last updated: Feb. 23, 2023
- Non-Antineoplastic HD PPE and Disposal
- Non-Antineoplastic HD Hazardous Drug Safe Handling Policy
- Black Box Warning: Lamivudine: Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation
- Black Box Warning: Zidovudine: Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
NON-formulary medication